Miricorilant: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1

Condition	Trials
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis	1
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)	1
NASH	1
Non-alcoholic Fatty Liver Disease (NAFLD)	1
Nonalcoholic Steatohepatitis (NASH)	1

Evaluating the Pharmacokinetics and Safety of Miricorilant
NCT07553663 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

1 recruiting trial across 5 conditions.

No. For the full record, search ClinicalTrials.gov.